{{Rsnum
|rsid=4035540
|Gene=CHEK2
|Chromosome=22
|position=28691053
|Orientation=plus
|GMAF=0.2351
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=CHEK2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 48.7 | 42.5 | 8.8
| HCB | 51.8 | 43.1 | 5.1
| JPT | 68.8 | 29.5 | 1.8
| YRI | 63.3 | 34.0 | 2.7
| ASW | 52.6 | 31.6 | 15.8
| CHB | 51.8 | 43.1 | 5.1
| CHD | 49.1 | 47.2 | 3.7
| GIH | 63.4 | 31.7 | 5.0
| LWK | 74.5 | 22.7 | 2.7
| MEX | 58.6 | 36.2 | 5.2
| MKK | 0.0 | 0.0 | 0.0
| TSI | 58.8 | 36.3 | 4.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=19855918
|Title=Variation in the checkpoint kinase 2 gene is associated with type 2 diabetes in multiple populations
|OA=1
}}

{{PMID Auto
|PMID=17428325
|Title=Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk.
|OA=1
}}

{{PMID Auto
|PMID=19087964
|Title=Correcting estimators of theta and Tajima's D for ascertainment biases caused by the single-nucleotide polymorphism discovery process.
|OA=1
}}

{{PMID Auto
|PMID=19265784
|Title=The association of cell cycle checkpoint 2 variants and kidney function: findings of the Family Blood Pressure Program and the Atherosclerosis Risk In Communities study.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}